The recent advent of national family planning programs and the expansion of local programs have created an acute need for accurate statistical evaluation of contraceptive methods. Effectiveness in terms of pregnancy rates and continuation or discontinuation of use of the contraceptive method or methods under study have emerged as the major criteria in such evaluations.
For more than a quarter of a century, scholars concerned with the evaluation of contraceptive methods have distinguished between theoretical effectiveness' and useeffectiveness." Theoretical effectiveness, also known as biological! or physiological' effectiveness, refers to the antifei tility action of a method or product under ideal conditions. If it were possible to place a human population in a laboratory setting it would also be possible to ensure consistent use of a contraceptive without error or omission. In such situations, the interaction between chemical or mechanical factors and human physiology determines the degree of effectiveness."As it is, a high level of theoretical effectiveness can * The Population Council, New York.
be approached in human populations, and perhaps even achieved, but it cannot ordinarily be verified.
CONCEPTS OF USE-EFFECTIVENESS
Use-effectiveness, also known as clinical effectiveness,"relates to the experience of a human population with contraception in general or with a particular method or product, while exposed to the risk of unintended pregnancy. Traditionally, the term covers all periods of use, including irregularities in contraceptive practice, but excludes periods of nonuse that follow discontinuation of contraception. In studies of a specific method, change to another method also terminates the period of exposure under consideration.
The use-effectiveness of a method may be expected to be significantly lower than the theoretical effectiveness of the same method if periodic action is required, regardless of whether or not such action is coitus-related. With such methods, the theoretical effectiveness may be inferred from the levels of use-effectiveness that are achieved by the most successful groups of highly motivated users. With quasi-permanent methods, such as intrauterine devices, use-effectiveness tends to approach theoretical effectiveness.
In 1959, a new term, demographic effectiveness," was applied to the evaluation of the experience of couples who had adopted contraception and who had remained exposed to the risk of unintended pregnancy, whether or not they continued their contraceptive practice. This cencept extended the period of exposure to include periods of nonuse following the adoption of contraception, as well as periods of use. Effectiveness, thus defined, may be substantially lower than use-effectiveness in the traditional sense, if many couples abandon their contraceptive efforts after short periods of initial use. Because the term "demographic effectiveness" appears too broad and perhaps over-ambitious in this context, it is proposed that it be replaced by the term "extended use-effectiveness," which retains the relationship between the new concept and the traditional one. Distinction between use-effectiveness and extended use-effectiveness is particularly relevant to programs that involve oral and intrauterine contraception, because these methods permit a more precise separation of periods of use from periods of nonuse than is possible with traditional contraception.
Most research on contraceptive effectiveness over the past thirty years has been conducted by clinicians, and much of it has been sponsored by manufacturers of contraceptives. Since clinicians are primarily method-oriented and manufacturers are product-oriented, and since theoretical effectiveness cannot be evaluated directly in human populations, the emphasis in clinical studies has been on use-effectiveness. Very few clinicians have tried to follow patients or clients beyond the point at which the prescribed method was abandoned.s Although extended useeffectiveness has in fact been evaluated in a few studies based on interviews with samples of the general population," no 8 Beebe, op. cii., pp. 124-37; C. Chandrasekaran and K. Kuder attention was paid to the conceptual differences between this approach and use-effectiveness in the traditional sense, nor have these differences been discussed in the literature.
COMPUTATION OF PREGNANCY RATES
Since the 1930's, the accepted measure of contraceptive effectiveness has been the pregnancy rate per 100 woman-years of use, computed according to Pearl's formula, R = P X 1,200jM, in which the numerator is the number of accidental pregnancies multipled by 1,200, and the denominator is the aggregate of all months of exposure contributed by all couples included in the investigation." Pearl's formula assumes a constant pregnancy rate for a given population in all months following the initiation of contraceptive practice. In other words, the pregnancy rate for 50 women observed for two years is equated to that for 100 women observed for one year or to that for 200 women observed for six months.
According to a number of observations, pregnancy rates vary with duration of use. In studies of use-effectiveness, pregnancy rates tend to decline with duration of use," sometimes steeply. In studies of extended use-effectiveness, pregnancy rates can be expected to increase for a time as couples abandon contraception, and then to decline gradually. Empirical data are not yet available. In view of these relationships, Pearl's formula can no longer be considered an adequate tool for the evaluation of contraceptive effectiveness, and its abandonment in favor of cumulative pregnancy rates based on life table procedures is strongly recommended.
The life table is also the preferred procedure for the computation of cumulative rates of continuation and discontinuation 10 R. Pearl, "Contraception and Fertility in 2,000 Women," Human Biology, IV (September, 1932), 363-407. of contraceptive practice in general or of specific contraceptive methods" to which clinicians and demographers have increasingly turned their attention in recent years.
Cumulative pregnancy rates and continuation rates may be computed as gross rates, using a single-decrement life table," and measuring effectiveness and continuation as isolated phenomena. In terms of use-effectiveness, cumulative rates may also be computed as net rates, using a multiple-decrement life table, 14 which takes into account the competing effects of pregnancies and other types of discontinuations. The rate of continuation is the complement of the sum of the net rates of discontinuation.
The computation of gross and net rates is a comparatively simple procedure if the period of exposure is limited to a single pregnancy interval. With this limitation, resumption of contraception after a pregnancy, accidental or planned, initiates a new period of exposure which may be handled as a new case. It is also recommended that, for routine evaluation, the life table analysis be confined either to contraceptive practice in general, regardless of method, or to the first method or product prescribed for, or chosen by, each patient or client. Evaluation of methods other than the first requires the separation of the user's experience into "segments" and the combination of these segments into "synthetic cohorts" of experience.IS The basic data required for this approach cannot be obtained in many situations, nor does the additional information usually justify the greatly increased volume and expense of computation.
In the authors' opinion, extended useeffectiveness is more relevant to the evaluation of the contraceptive practice in national and local programs than is useeffectiveness in the traditional sense. In addition, pregnancy rates computed in terms of extended use-effectiveness are subject to fewer errors since most periods of nonuse need not be separated from periods of use. It is recommended, nevertheless, that insofar as possible each user be classified in terms of use-effectiveness as well as in terms of extended use-effectiveness since continuation rates can be computed in terms of the former concept only.
CLASSIFICATION BY TERMINAL STATUS
In addition to whatever demographic and sociologic variables appear relevant, each woman included in the study should be classified by (1) first method or product prescribed or chosen, (2) terminal status, and (3) duration of use or exposure. Classification by terminal status and by duration of use or exposure varies with the focus of the analysis. The four basic types of analysis are (1) use-effectiveness of all contraception, (2) use-effectiveness of the first method, (3) extended useeffectiveness of all contraception, and (4) extended use-effectiveness of the first method (Table 1) .
In terms of use-effectiveness of all contraception, (that is, without regard to method), the period of exposure begins with the initiation of use and terminates with anyone of the following six statuses: 14 R. G. Potter, "The Multiple Decrement Life to the risk of pregnancy that last one 2. Accidental pregnancy while using contra-month or longer and are followed by reception 3. Discontinuation of contraception without sumption of use are omitted; periods of desire for protection (planning pregnancy) use that precede and follow these inter-4. Discontinuation without need for protee-ruptions are added; and the duration of tion (for example, separation from hus-exposure is treated as a single continuing band) period. Interruptions of use in studies of 5. Discontinuation-s-other (discontinuation use-effectiveness of the first method are with continued exposure to the risk of un-treated in the same way as in studies of intended pregnancy) use-effectiveness in general, except that 6. Loss to follow-up (LFU) periods of use of another method, folInvestigation of the use-effectiveness of lowed by resumption of the first method, the first contraceptive method requires an as well as periods of nonuse, are omitted additional classification of terminal sta-from the duration of use. Under some tus: (7) change of method." The two ter-circumstances, it may not be possible to minal statuses (5 and 7, may be further identify periods of temporary nonuse or subdivided into: (a) expulsions of an use of another method, especially in retIUeD, (b) removals and other termina-rospective studies. However, the overtions for medical reasons, and (c) termina-estimation of use that may result from tions for personal reasons. It is important ignoring such periods is probably not a to define these categories precisely in major source of error. order to avoid overlapping.
In terms of extended use-effectiveness In studies of use-effectiveness of all of contraceptive practice in general, percontraceptive practice, irregularities and iods of nonuse are assimilated to the brief periods of nonuse are disregarded in preceding periods of use. The period of computing months of use. However, peri-exposure begins with the initiation of con- 18 In clinical trials, some women who are well traception and terminates in one of the satisfied withthe method andhave nocomplaints following five statuses. may bechanged to othermethods at theinitiative of the investigator, for reasons connected with 1. Not pregnant but exposed to risk at end of the research. The appropriate terminal status for observation, whether or not using contrasuch cases is that ofuser as ofthe date ofchange. ception Table I The following six terminal statuses are required for the evaluation of extended use-effectiveness of the first method prescribed or chosen. 1. Not pregnant but exposed to risk at end of observation and either using the first method or not using contraception 2. Accidental pregnancy during use of first method or during nonuse 3. Discontinuation for planning pregnancy 4. Discontinuation without need for protection 5. Change of method 6. LFU.
Periods of nonuse that immediately follow periods of use of the first method are included in the period of exposure. Periods of use of another method, and periods of nonuse without need for protection, followed by resumption of the first method, are omitted in the determination of duration of exposure.
Some retrospective studies are based entirely on follow-up interviews with women who had accepted contraceptive services at the initial contact but for whom no other information is available in clinical or other service records. In such studies, the analysis is based on the information obtained at the interview. In other studies information for some cases may be based entirely on clinical or other service records, and for other cases, partly on such records and partly on information obtained at follow-up interviews. In retrospective studies, a common cutoff for all cases is ordinarily established. The last day of a calendar month is the most convenient for that purpose. In prospective studies the same procedure may be followed, or cutoff dates may be assigned individually; for example, at the end of the twelfth month or of the twentyfourth month after the initial contact.
It is recommended that follow-up visits be made several months after cutoff date. The two major advantages of this procedure are (1) pregnancies that occur prior to the cutoff data can be more easily identified; and (2) active users may return to the clinic for checkup or supplies. (This reduces the number of acceptors who have to be visited.)
ADJUSTMENT FOR LOSS TO FOLLOW-UP
It will be noted that each of the four types of analysis of contraceptive effectiveness includes the category "LFU" (cases lost to follow-up)." In the past, such cases have been handled in various ways, usually depending on the type of contraceptive studied. In order to achieve a uniform procedure for statistical evaluation, it is recommended that LFU cases be distributed pro rata, according to the terminal status and duration of use or exposure of acceptors from whom information was obtained by a successful follow-up interview.
To apply this procedure, it is necessary to determine, first, those women among the acceptors who are subject to follow-up visits, and, second, those who are lost to follow-up. Women whose clinic or service records provide the following information need not be visited. 1. Continuing users on a predetermined cutoff date, as evidenced by the verified presence of an IUCD or by continuing uptake of oral tablets or other supplies, after that date 2. Those who are pregnant under known circumstances as to use (including method used) or nonuse of contraception 3. Those who, or whose husbands, had undergone surgical sterilization.IS All other women are followed up after the cutoff data although their experience is evaluated up to that date only. All women who are subject to follow-up (those who did not return to the clinic after the cutoff date and whose clinical record did not show a pregnancy under known circumstances or surgical sterilization) are classified by status at last contact with the clinic (SLC), within first method prescribed or chosen. SLC includes insertion, presence, expulsion, or removal of an IUCD; prescription, continuing use, or discontinuation of oral or traditional methods; pregnancy under unknown circumstances; and suspected, but unconfirmed pregnancy. Each SLC group is further distributed by time elapsed between first acceptance and last contact. Women whose follow-up was unsuccessful (no contact was established at the follow-up visit) are classified as lost to follow-up.
For LFU cases without information after the first clinic visit, a randomly selected record is substituted from among those women who were successfully interviewed; who had accepted the same contraceptive method at about the same time; and for whom comparable personal characteristics, such as age and parity, were recorded at the time of initial contact.
In a situation where some information on LFU users can be obtained from their clinical records, a more sophisticated, but more laborious, approach to their pro-rata distribution enables the investigator to take into account the experience contained in the clinic records. For such cases a record is substituted of a woman in the same SLC group who was successfully interviewed after the cutoff date, selecting the one that most closely approximates the LFU case in terms of time elapsed between first acceptance and last contact. If several interviewed cases are equally close to the LFU case, the one that is most similar in terms of personal characteristics and/or date of acceptance should be substituted. However, if the clinic record of an LFU case shows a pregnancy under circumstances as to use or nonuse of contraception, or a suspected pregnancy, and no successfully interviewed woman with the same SLC can be found, a pregnancy should be assumed to have occurred during use of the method most recently prescribed or chosen.
Successful follow-up is not feasible unless clinical or other service records contain complete and specific information on the identity and residence of acceptors. Even with this information, efforts at locating acceptors must be pursued energetically if they are to succeed. Universally valid standards of follow-up cannot be established. What would be considered a creditable performance in one country might be considered a dismal failure elsewhere. Figure 1 presents 12 examples of contraceptive experience over a period of 24 months following initiation of contraception. Six categories of use and nonuse are distinguished: (1) use of the first method prescribed or chosen, (2) use of other methods, (3) nonuse for planning pregnancy, (4) nonuse with no needfor protection, (5) other nonuse that is, nonuse with continuing exposure to the risk of unintended conception, and (6) pregnancy. Case No. 8.-This woman used the first method for ten months, then another method for five months, and no method for five additional months, followed by conception. For the assessment of all contraception in terms of use-effectiveness she is classified as discontinuation-other with 15 months of use; in terms of extended use-effectiveness, as accidental pregnancy with 20 months of exposure. For the evaluation of the first method in terms of either use-effectiveness or extended use-effectiveness, she is classified as change of method with 10 months of use.
EXAMPLES OF CLASSIFICATIONS
Case No. B.-While this woman was still using the first method at the cutoff date, she experienced two interruptions of continuity: once for a single month and once for three months, each time without protection. For the analysis of use-effectiveness, she is classified as a user, with 20 months of use. For the analysis of extended use-effectiveness she remains at risk with 24 months of exposure. Case No. to.-This woman changed to another method, used it for six months, and then returned to the first method. For the analysis of use-effectiveness she is classified as a user; in terms of extended use-effectiveness she remains at risk. She is credited with 24 months of use or exposure for all contraception and with 18 months for the first method.
Case No. 11.-This woman used the first method for six months and then was separated from her husband for a period of eight months. After his return, the use of the first method was resumed. For the analysis of use-effectiveness, she is classified as a user; in terms of extended useeffectiveness she remains at risk. She is credited with 16 months of use or exposure for all four types of analysis.
Case No. t2.-This woman used the first method for nine months, then no method for three months (husband present), and then another method for eight additional months. Subsequently, contraception was once more abandoned, although pregnancy was not desired. In terms of use-effectiveness of all contraception, she is classified as discontinuation-other with 17 months of use; in terms of use-effectiveness of the first method, as change of method with 9 months of use.
In terms of extended use-effectiveness, of all contraception, she is at risk with 24 months of exposure, in terms of extended use-effectiveness of the first method, she is closed as change of method with 12 months of exposure.
A follow-up record, from which the information required for a fourfold classification by terminal status and duration of use or exposure can be obtained, is shown in Figure 2 . It is designed for a retrospective study of women who had previously accepted contraceptive service in a family planning clinic. The proposed record does not attempt to elicit information on periods of nonuse, followed by resumption of contraception. It includes a question on outcome of pregnancy which is not required for the analysis of useeffectiveness or extended use-effectiveness within a pregnancy interval but may furnish important additional information.
The authors hope that they have clarified the distinction, frequently overlooked, between use-effectiveness and extended use-effectiveness. Moreover,they hope that in doing so they have provided a coherent framework for evaluating the use-effectiveness, in both senses, of contraception as well as its continuation.
